Trial Profile
An Open-Label Drug-Drug Interaction Study to Assess the Effect of Abiraterone (JNJ-589485) on the Pharmacokinetics of Pioglitazone Following Administration of Abiraterone Acetate (JNJ-212082) and Pioglitazone HCl Tablets in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Aug 2013
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Pioglitazone
- Indications Prostate cancer; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 01 Jul 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jun 2013 New trial record